In re Zetia (Ezetimibe) Antitrust Litigation, Case No. 2:18-md-2836 (E.D. Va.)
We are excited to announce the settlement of this class action lawsuit. The case involved alleged pay-for-delay antitrust violations by various defendants. Plaintiffs alleged that Defendants unlawfully delayed the availability of allegedly less-expensive generic versions of Zetia and that Defendants’ alleged conduct caused third-party payors to pay too much for branded and generic Zetia […]